Drugmakers Eye $23 Billion Biotech Argenx Ahead of Key Data
European biotech firm Argenx SE is scheduled to release key drug trial data this summer. Deal-hungry Big Pharma
2023-05-17 16:20
FTC to Sue to Block Amgen’s Takeover of Horizon Therapeutics
The US Federal Trade Commission is expected to file a lawsuit Tuesday to block Amgen Inc.’s $27.8 billion
2023-05-16 09:22